Conflict of Interest in Oncology Publications: A Survey of Disclosure Policies and Statements

Kesselheim AS, Lee JL, Avorn J, Servi A, Shrank WH, Choudhry NK - Cancer

  • Regulation and Clinical Evidence

Summary:

Most oncology journals had conflict-of-interest policies, with 94% requiring financial disclosure and 42% also seeking nonfinancial disclosures. However, only 61% of higher-impact journals consistently published disclosure statements in over 90% of articles, and no nonfinancial conflicts were published in any reviewed article. Only 52% of journals published disclosures for editorials and commentaries. Given these inconsistencies in disclosure practices across oncology journals, standardized, comprehensive conflict-of-interest reporting policies are necessary.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

The Impact of Semantics in Medicines Regulation

Costa E, Kesselheim AS - Journal of Law, Medicine, & Ethics

  • Innovation Incentives and Competition
  • Regulation and Clinical Evidence